Asian Pacific association for the study of liver (APASL) guidelines: hepatitis B virus in pregnancy

Manoj Kumar1, Zaigham Abbas2, Milad Azami3

  • 1Department of Hepatology and Liver Transplantation, Institute of Liver and Biliary Sciences, D1 Vasant Kunj, New Delhi, 110070, India. manojkumardm@gmail.com.

Hepatology International
|February 3, 2022
PubMed

Insights

Hepatitis B virus (HBV) infection management during pregnancy is crucial in Asia-Pacific. These guidelines offer recommendations for pregnant individuals with HBV and their infants, addressing critical care and follow-up strategies.

Area of Science:

  • Hepatology
  • Public Health
  • Infectious Diseases

Background:

  • Hepatitis B virus (HBV) infection is a significant public health concern in the Asia-Pacific region.
  • Perinatal and early childhood exposure contribute substantially to the HBV disease burden.
  • Pregnancy with Hepatitis B presents unique challenges for maternal and fetal health.

Purpose of the Study:

  • To provide comprehensive guidelines for managing females with HBV infection throughout pregnancy and postpartum.
  • To address specific concerns and management challenges related to HBV in pregnant individuals.
  • To outline follow-up protocols for infants born to mothers with Hepatitis B.

Main Methods:

  • Systematic review of existing literature on HBV management in pregnancy.
  • Evidence-based recommendations developed by the Asia-Pacific Association for the Study of the Liver (APASL).
  • Focus on all stages of pregnancy, postpartum period, and infant care.

Main Results:

  • Detailed recommendations for antiviral therapy and monitoring during pregnancy.
  • Strategies for preventing perinatal transmission of HBV.
  • Guidance on infant vaccination and follow-up protocols.

Conclusions:

  • Effective management of HBV in pregnant individuals is essential for maternal and infant outcomes.
  • Adherence to APASL guidelines can mitigate the impact of HBV infection in the Asia-Pacific region.
  • Comprehensive care throughout pregnancy, postpartum, and infancy is critical for controlling HBV-related diseases.

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...